A carregar...
728. Activity of Eravacycline Against Contemporary Gram-Negative Clinical Isolates From New York City Hospitals
BACKGROUND: Antibiotic-resistant Gram-negative bacteria, including KPC-producing Enterobacteriaceae and carbapenem-resistant A. baumannii, have been problematic hospital pathogens in NYC and other areas. Eravacycline (ERV), a fluorocycline antibiotic released in the USA in 2018, has demonstrated in...
Na minha lista:
| Publicado no: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811199/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.796 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|